A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

NCT05238441 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Sars-CoV-2 Infection

Interventions

BIOLOGICAL: SCTV01E
BIOLOGICAL: Comirnaty
BIOLOGICAL: SCTV01E
BIOLOGICAL: Comirnaty

Sponsor

Sinocelltech Ltd.